The global Non-invasive Parenteral Screening Instruments market was valued at US$ 3812 million in 2023 and is anticipated to reach US$ 7241.6 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.

Non-invasive Parenteral Screening Instruments Market

Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-invasive Parenteral Screening Instruments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Parenteral Screening Instruments.

Report Scope

The Non-invasive Parenteral Screening Instruments market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-invasive Parenteral Screening Instruments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-invasive Parenteral Screening Instruments companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-invasive Parenteral Screening Instruments Market Report

Report Metric	Details
Report Name	Non-invasive Parenteral Screening Instruments Market
Accounted market size in 2023	US$ 3812 million
Forecasted market size in 2030	US$ 7241.6 million
CAGR	9.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Ultrasound Devices Next-Generation Sequencing Systems Polymerase Chain Reaction Instruments Microarrays Others
Segment by Application	Diagnostic Laboratories Hospitals
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-invasive Parenteral Screening Instruments companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-invasive Parenteral Screening Instruments Market growing?

Ans: The Non-invasive Parenteral Screening Instruments Market witnessing a CAGR of 9.6% during the forecast period 2024-2030.

What is the Non-invasive Parenteral Screening Instruments Market size in 2030?

Ans: The Non-invasive Parenteral Screening Instruments Market size in 2030 will be US$ 7241.6 million.

Who are the main players in the Non-invasive Parenteral Screening Instruments Market report?

Ans: The main players in the Non-invasive Parenteral Screening Instruments Market are GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group

What are the Application segmentation covered in the Non-invasive Parenteral Screening Instruments Market report?

Ans: The Applications covered in the Non-invasive Parenteral Screening Instruments Market report are Diagnostic Laboratories, Hospitals

What are the Type segmentation covered in the Non-invasive Parenteral Screening Instruments Market report?

Ans: The Types covered in the Non-invasive Parenteral Screening Instruments Market report are Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Ultrasound Devices

1.2.3 Next-Generation Sequencing Systems

1.2.4 Polymerase Chain Reaction Instruments

1.2.5 Microarrays

1.2.6 Others

1.3 Market by Application

1.3.1 Global Non-invasive Parenteral Screening Instruments Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Diagnostic Laboratories

1.3.3 Hospitals

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-invasive Parenteral Screening Instruments Market Perspective (2019-2030)

2.2 Non-invasive Parenteral Screening Instruments Growth Trends by Region

2.2.1 Global Non-invasive Parenteral Screening Instruments Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-invasive Parenteral Screening Instruments Historic Market Size by Region (2019-2024)

2.2.3 Non-invasive Parenteral Screening Instruments Forecasted Market Size by Region (2025-2030)

2.3 Non-invasive Parenteral Screening Instruments Market Dynamics

2.3.1 Non-invasive Parenteral Screening Instruments Industry Trends

2.3.2 Non-invasive Parenteral Screening Instruments Market Drivers

2.3.3 Non-invasive Parenteral Screening Instruments Market Challenges

2.3.4 Non-invasive Parenteral Screening Instruments Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-invasive Parenteral Screening Instruments Players by Revenue

3.1.1 Global Top Non-invasive Parenteral Screening Instruments Players by Revenue (2019-2024)

3.1.2 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Players (2019-2024)

3.2 Global Non-invasive Parenteral Screening Instruments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Non-invasive Parenteral Screening Instruments Revenue

3.4 Global Non-invasive Parenteral Screening Instruments Market Concentration Ratio

3.4.1 Global Non-invasive Parenteral Screening Instruments Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Instruments Revenue in 2023

3.5 Non-invasive Parenteral Screening Instruments Key Players Head office and Area Served

3.6 Key Players Non-invasive Parenteral Screening Instruments Product Solution and Service

3.7 Date of Enter into Non-invasive Parenteral Screening Instruments Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-invasive Parenteral Screening Instruments Breakdown Data by Type

4.1 Global Non-invasive Parenteral Screening Instruments Historic Market Size by Type (2019-2024)

4.2 Global Non-invasive Parenteral Screening Instruments Forecasted Market Size by Type (2025-2030)

5 Non-invasive Parenteral Screening Instruments Breakdown Data by Application

5.1 Global Non-invasive Parenteral Screening Instruments Historic Market Size by Application (2019-2024)

5.2 Global Non-invasive Parenteral Screening Instruments Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-invasive Parenteral Screening Instruments Market Size (2019-2030)

6.2 North America Non-invasive Parenteral Screening Instruments Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024)

6.4 North America Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-invasive Parenteral Screening Instruments Market Size (2019-2030)

7.2 Europe Non-invasive Parenteral Screening Instruments Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024)

7.4 Europe Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-invasive Parenteral Screening Instruments Market Size (2019-2030)

8.2 Asia-Pacific Non-invasive Parenteral Screening Instruments Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024)

8.4 Asia-Pacific Non-invasive Parenteral Screening Instruments Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-invasive Parenteral Screening Instruments Market Size (2019-2030)

9.2 Latin America Non-invasive Parenteral Screening Instruments Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024)

9.4 Latin America Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size (2019-2030)

10.2 Middle East & Africa Non-invasive Parenteral Screening Instruments Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024)

10.4 Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GE Healthcare

11.1.1 GE Healthcare Company Detail

11.1.2 GE Healthcare Business Overview

11.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Introduction

11.1.4 GE Healthcare Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)

11.1.5 GE Healthcare Recent Development

11.2 Philips

11.2.1 Philips Company Detail

11.2.2 Philips Business Overview

11.2.3 Philips Non-invasive Parenteral Screening Instruments Introduction

11.2.4 Philips Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)

11.2.5 Philips Recent Development

11.3 Illumina

11.3.1 Illumina Company Detail

11.3.2 Illumina Business Overview

11.3.3 Illumina Non-invasive Parenteral Screening Instruments Introduction

11.3.4 Illumina Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)

11.3.5 Illumina Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Detail

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Introduction

11.4.4 Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Non-invasive Parenteral Screening Instruments Introduction

11.5.4 Roche Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)

11.5.5 Roche Recent Development

11.6 PacBio

11.6.1 PacBio Company Detail

11.6.2 PacBio Business Overview

11.6.3 PacBio Non-invasive Parenteral Screening Instruments Introduction

11.6.4 PacBio Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)

11.6.5 PacBio Recent Development

11.7 Perkinelmer

11.7.1 Perkinelmer Company Detail

11.7.2 Perkinelmer Business Overview

11.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Introduction

11.7.4 Perkinelmer Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)

11.7.5 Perkinelmer Recent Development

11.8 Qiagen

11.8.1 Qiagen Company Detail

11.8.2 Qiagen Business Overview

11.8.3 Qiagen Non-invasive Parenteral Screening Instruments Introduction

11.8.4 Qiagen Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)

11.8.5 Qiagen Recent Development

11.9 Agilent Technologies

11.9.1 Agilent Technologies Company Detail

11.9.2 Agilent Technologies Business Overview

11.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Introduction

11.9.4 Agilent Technologies Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)

11.9.5 Agilent Technologies Recent Development

11.10 BGI Group

11.10.1 BGI Group Company Detail

11.10.2 BGI Group Business Overview

11.10.3 BGI Group Non-invasive Parenteral Screening Instruments Introduction

11.10.4 BGI Group Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024)

11.10.5 BGI Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

GE Healthcare

Philips

Illumina Inc

Thermo Fisher Scientific

List of Tables

Table 1. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Ultrasound Devices

Table 3. Key Players of Next-Generation Sequencing Systems

Table 4. Key Players of Polymerase Chain Reaction Instruments

Table 5. Key Players of Microarrays

Table 6. Key Players of Others

Table 7. Global Non-invasive Parenteral Screening Instruments Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Non-invasive Parenteral Screening Instruments Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Non-invasive Parenteral Screening Instruments Market Share by Region (2019-2024)

Table 11. Global Non-invasive Parenteral Screening Instruments Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Non-invasive Parenteral Screening Instruments Market Share by Region (2025-2030)

Table 13. Non-invasive Parenteral Screening Instruments Market Trends

Table 14. Non-invasive Parenteral Screening Instruments Market Drivers

Table 15. Non-invasive Parenteral Screening Instruments Market Challenges

Table 16. Non-invasive Parenteral Screening Instruments Market Restraints

Table 17. Global Non-invasive Parenteral Screening Instruments Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Non-invasive Parenteral Screening Instruments Market Share by Players (2019-2024)

Table 19. Global Top Non-invasive Parenteral Screening Instruments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening Instruments as of 2023)

Table 20. Ranking of Global Top Non-invasive Parenteral Screening Instruments Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Non-invasive Parenteral Screening Instruments Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Non-invasive Parenteral Screening Instruments Product Solution and Service

Table 24. Date of Enter into Non-invasive Parenteral Screening Instruments Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Non-invasive Parenteral Screening Instruments Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2019-2024)

Table 28. Global Non-invasive Parenteral Screening Instruments Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2025-2030)

Table 30. Global Non-invasive Parenteral Screening Instruments Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2019-2024)

Table 32. Global Non-invasive Parenteral Screening Instruments Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2025-2030)

Table 34. North America Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Non-invasive Parenteral Screening Instruments Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Non-invasive Parenteral Screening Instruments Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size by Country (2025-2030) & (US$ Million)

Table 49. GE Healthcare Company Detail

Table 50. GE Healthcare Business Overview

Table 51. GE Healthcare Non-invasive Parenteral Screening Instruments Product

Table 52. GE Healthcare Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)

Table 53. GE Healthcare Recent Development

Table 54. Philips Company Detail

Table 55. Philips Business Overview

Table 56. Philips Non-invasive Parenteral Screening Instruments Product

Table 57. Philips Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)

Table 58. Philips Recent Development

Table 59. Illumina Company Detail

Table 60. Illumina Business Overview

Table 61. Illumina Non-invasive Parenteral Screening Instruments Product

Table 62. Illumina Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)

Table 63. Illumina Recent Development

Table 64. Thermo Fisher Scientific Company Detail

Table 65. Thermo Fisher Scientific Business Overview

Table 66. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product

Table 67. Thermo Fisher Scientific Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)

Table 68. Thermo Fisher Scientific Recent Development

Table 69. Roche Company Detail

Table 70. Roche Business Overview

Table 71. Roche Non-invasive Parenteral Screening Instruments Product

Table 72. Roche Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)

Table 73. Roche Recent Development

Table 74. PacBio Company Detail

Table 75. PacBio Business Overview

Table 76. PacBio Non-invasive Parenteral Screening Instruments Product

Table 77. PacBio Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)

Table 78. PacBio Recent Development

Table 79. Perkinelmer Company Detail

Table 80. Perkinelmer Business Overview

Table 81. Perkinelmer Non-invasive Parenteral Screening Instruments Product

Table 82. Perkinelmer Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)

Table 83. Perkinelmer Recent Development

Table 84. Qiagen Company Detail

Table 85. Qiagen Business Overview

Table 86. Qiagen Non-invasive Parenteral Screening Instruments Product

Table 87. Qiagen Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)

Table 88. Qiagen Recent Development

Table 89. Agilent Technologies Company Detail

Table 90. Agilent Technologies Business Overview

Table 91. Agilent Technologies Non-invasive Parenteral Screening Instruments Product

Table 92. Agilent Technologies Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)

Table 93. Agilent Technologies Recent Development

Table 94. BGI Group Company Detail

Table 95. BGI Group Business Overview

Table 96. BGI Group Non-invasive Parenteral Screening Instruments Product

Table 97. BGI Group Revenue in Non-invasive Parenteral Screening Instruments Business (2019-2024) & (US$ Million)

Table 98. BGI Group Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-invasive Parenteral Screening Instruments Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Non-invasive Parenteral Screening Instruments Market Share by Type: 2023 VS 2030

Figure 3. Ultrasound Devices Features

Figure 4. Next-Generation Sequencing Systems Features

Figure 5. Polymerase Chain Reaction Instruments Features

Figure 6. Microarrays Features

Figure 7. Others Features

Figure 8. Global Non-invasive Parenteral Screening Instruments Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Non-invasive Parenteral Screening Instruments Market Share by Application: 2023 VS 2030

Figure 10. Diagnostic Laboratories Case Studies

Figure 11. Hospitals Case Studies

Figure 12. Non-invasive Parenteral Screening Instruments Report Years Considered

Figure 13. Global Non-invasive Parenteral Screening Instruments Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Non-invasive Parenteral Screening Instruments Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Non-invasive Parenteral Screening Instruments Market Share by Region: 2023 VS 2030

Figure 16. Global Non-invasive Parenteral Screening Instruments Market Share by Players in 2023

Figure 17. Global Top Non-invasive Parenteral Screening Instruments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening Instruments as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Non-invasive Parenteral Screening Instruments Revenue in 2023

Figure 19. North America Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Non-invasive Parenteral Screening Instruments Market Share by Country (2019-2030)

Figure 21. United States Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Non-invasive Parenteral Screening Instruments Market Share by Country (2019-2030)

Figure 25. Germany Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Non-invasive Parenteral Screening Instruments Market Share by Region (2019-2030)

Figure 33. China Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Non-invasive Parenteral Screening Instruments Market Share by Country (2019-2030)

Figure 41. Mexico Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Share by Country (2019-2030)

Figure 45. Turkey Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Non-invasive Parenteral Screening Instruments Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. GE Healthcare Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)

Figure 48. Philips Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)

Figure 49. Illumina Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)

Figure 51. Roche Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)

Figure 52. PacBio Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)

Figure 53. Perkinelmer Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)

Figure 54. Qiagen Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)

Figure 55. Agilent Technologies Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)

Figure 56. BGI Group Revenue Growth Rate in Non-invasive Parenteral Screening Instruments Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions